av/biotest-ag-st-o-n--big.svg

COM:BIOTEST

Biotest AG

  • Stock

EUR

Last Close

41.60

25/11 08:02

Market Cap

1.40B

Beta: -

Volume Today

10

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
236.50M
-
232.35M
1.75%
194.75M
16.18%
158.85M
18.43%
177.60M
11.80%
244.20M
37.50%
285.10M
16.75%
267.35M
6.23%
269.20M
0.69%
356.45M
32.41%
average payables
53.45M
-
54.30M
1.59%
57.95M
6.72%
63.90M
10.27%
69.20M
8.29%
62.80M
9.25%
47.10M
25%
40.40M
14.23%
44.95M
11.26%
64.60M
43.72%
average receivables
162.75M
-
204.10M
25.41%
212.10M
3.92%
242.70M
14.43%
226.80M
6.55%
167.95M
25.95%
165.70M
1.34%
166.40M
0.42%
171.45M
3.03%
196.35M
14.52%
book value per share
12.13
-
10.42
14.14%
9.11
12.54%
8.78
3.58%
12.51
42.41%
12.05
3.66%
11.16
7.40%
9.61
13.86%
9.38
2.44%
12.61
34.44%
capex per share
-1.13
-
-2.54
125.28%
-3.64
42.90%
-2.69
25.99%
-1.38
48.73%
-0.86
37.55%
-0.68
20.82%
-0.46
32.59%
-0.74
60.99%
-0.84
13.99%
capex to depreciation
-1.38
-
-1.07
22.28%
-6.28
487.82%
-4.78
24.00%
-2.21
53.71%
-1.08
51.34%
-0.91
15.20%
-0.59
35.84%
-0.82
39.85%
-0.93
13.68%
capex to operating cash flow
3.92
-
-2.64
167.41%
-2.18
17.38%
-3.10
42.19%
1.09
135.17%
1.01
7.06%
1.62
59.31%
-0.54
133.21%
0.72
234.75%
20.88
2,785.45%
capex to revenue
-0.08
-
-0.17
122.38%
-0.26
52.33%
-0.28
8.26%
-0.14
51.58%
-0.08
40.35%
-0.06
31.47%
-0.04
36.70%
-0.06
60.83%
-0.05
14.06%
cash per share
5.92
-
3.88
34.34%
2.09
46.06%
0.71
65.98%
2.68
276.24%
2.17
19.23%
2.25
4.08%
2.97
31.73%
3.45
16.26%
3.00
13.10%
days of inventory on hand
251.16
-
178.06
29.10%
178.32
0.15%
210.60
18.10%
286.36
35.98%
352.18
22.98%
299.03
15.09%
205.29
31.35%
274.12
33.53%
370.66
35.22%
days payables outstanding
56.66
-
43.23
23.70%
65.57
51.66%
93.19
42.12%
100.91
8.29%
65.63
34.96%
43.29
34.04%
32.56
24.78%
47.68
46.41%
69.07
44.88%
days sales outstanding
122.98
-
131.30
6.76%
139.97
6.60%
263.83
88.49%
164.40
37.69%
135.51
17.57%
132.52
2.21%
111.14
16.13%
131.47
18.29%
110.26
16.14%
debt to assets
0.32
-
0.36
11.37%
0.37
3.68%
0.42
11.91%
0.32
23.91%
0.37
16.93%
0.41
12.21%
0.45
8.39%
0.48
6.21%
0.44
7.56%
debt to equity
0.69
-
0.84
20.93%
0.96
14.87%
1.17
21.75%
0.67
43.08%
0.86
29.07%
1.06
23.68%
1.30
22.82%
1.55
18.62%
1.28
17.44%
dividend yield
0.01
-
0.01
67.24%
0.00
83.00%
0.00
40.09%
0.00
71.06%
0.00
36.20%
0.00
33.33%
0.00
32.55%
0.00
0.23%
earnings yield
0.02
-
-0.11
783.98%
-0.07
34.71%
-0.00
94.65%
0.18
4,606.52%
-0.01
103.52%
-0.03
345.39%
-0.04
35.97%
-0.02
50.20%
0.07
498.18%
enterprise value
1.33B
-
1.03B
22.52%
902.49M
12.45%
1.28B
42.09%
1.30B
1.55%
1.11B
14.88%
1.54B
38.69%
2.08B
35.39%
2.15B
3.35%
2.28B
6.02%
enterprise value over ebitda
14.73
-
35.79
142.93%
9.97
72.14%
-68.21
784.01%
48.96
171.77%
43.99
10.15%
93.75
113.11%
-100.56
207.27%
94.36
193.83%
13.73
85.45%
ev to operating cash flow
-116.70
-
27.05
123.18%
13.69
49.38%
37.39
173.00%
-26.05
169.67%
-32.99
26.67%
-92.06
179.04%
61.40
166.70%
-53.12
186.51%
-1.43K
2,583.54%
ev to sales
2.29
-
1.75
23.52%
1.63
6.67%
3.39
107.86%
3.25
4.08%
2.65
18.69%
3.18
20.04%
4.04
27.15%
4.17
3.25%
3.33
20.08%
free cash flow per share
-1.42
-
-1.58
11.59%
-1.97
24.60%
-1.82
7.44%
-2.64
44.88%
-1.71
35.28%
-1.10
35.45%
0.40
135.93%
-1.76
544.59%
-0.88
49.86%
free cash flow yield
-0.05
-
-0.08
77.62%
-0.12
46.54%
-0.08
35.16%
-0.10
25.76%
-0.09
11.85%
-0.04
56.97%
0.01
124.23%
-0.04
543.55%
-0.02
50.32%
graham net net
-1.22
-
-3.24
165.99%
-6.18
90.78%
-8.19
32.42%
-5.10
37.78%
-7.30
43.36%
-8.18
11.95%
-9.26
13.18%
-10.34
11.67%
-11.68
12.98%
graham number
11.51
-
22.10
92.07%
15.40
30.32%
4.18
72.86%
35.95
759.82%
5.68
84.21%
14.12
148.72%
18.60
31.78%
12.98
30.21%
30.17
132.44%
income quality
-0.24
-
-0.51
110.96%
1.25
343.86%
-1.32
205.50%
8.33
731.68%
25.85
210.15%
0.56
97.85%
-0.53
196.05%
-1.28
138.94%
-0.01
99.01%
intangibles to total assets
0.05
-
0.05
4.49%
0.03
41.59%
0.02
37.45%
0.02
7.25%
0.01
20.87%
0.01
0.60%
0.01
18.04%
0.01
34.40%
0.00
69.53%
interest coverage
4.77
-
-8.35
275.11%
4.99
159.80%
-1.04
120.93%
0.97
193.07%
-0.61
162.47%
-0.93
53.02%
-3.95
324.60%
-0.66
83.28%
3.54
636.15%
interest debt per share
8.67
-
8.93
2.94%
9.07
1.64%
10.49
15.68%
8.60
18.06%
10.62
23.51%
12.21
14.99%
12.88
5.42%
15.01
16.58%
17.04
13.50%
inventory turnover
1.45
-
2.05
41.05%
2.05
0.15%
1.73
15.33%
1.27
26.46%
1.04
18.69%
1.22
17.77%
1.78
45.66%
1.33
25.11%
0.98
26.04%
invested capital
0.69
-
0.84
20.93%
0.96
14.87%
1.17
21.75%
0.67
43.08%
0.86
29.07%
1.06
23.68%
1.30
22.82%
1.55
18.62%
1.28
17.44%
market cap
1.18B
-
739.99M
37.18%
629.19M
14.97%
898.27M
42.77%
1.03B
15.20%
759.77M
26.58%
1.14B
50.00%
1.69B
48.26%
1.69B
0.23%
1.71B
0.93%
net current asset value
126.90M
-
36.40M
71.32%
-104.90M
388.19%
-181M
72.55%
-52M
71.27%
-108.70M
109.04%
-133.40M
22.72%
-201.60M
51.12%
-212.50M
5.41%
-188.90M
11.11%
net debt to ebitda
1.69
-
10.10
497.89%
3.02
70.09%
-20.43
776.54%
10.06
149.22%
13.84
37.64%
24.26
75.24%
-18.93
178.05%
20.07
206.03%
3.44
82.87%
net income per share
0.49
-
-2.08
529.69%
-1.16
44.48%
-0.09
92.36%
4.59
5,291.43%
-0.12
102.59%
-0.79
568.09%
-1.60
101.59%
-0.80
50.08%
3.21
501.90%
operating cash flow per share
-0.29
-
0.96
434.21%
1.67
72.97%
0.87
47.95%
-1.26
245.77%
-0.85
32.80%
-0.42
50.30%
0.86
302.99%
-1.02
219.47%
-0.04
96.05%
payables turnover
6.44
-
8.44
31.07%
5.57
34.06%
3.92
29.64%
3.62
7.65%
5.56
53.75%
8.43
51.60%
11.21
32.95%
7.66
31.70%
5.28
30.98%
receivables turnover
2.97
-
2.78
6.34%
2.61
6.19%
1.38
46.95%
2.22
60.48%
2.69
21.32%
2.75
2.26%
3.28
19.24%
2.78
15.46%
3.31
19.24%
research and ddevelopement to revenue
0.12
-
0.17
45.13%
0.09
47.67%
0.15
67.10%
0.12
17.31%
0.13
5.16%
0.12
9.55%
0.10
11.98%
0.10
3.54%
0.10
1.18%
return on tangible assets
0.02
-
-0.09
559.83%
-0.05
43.84%
-0.00
92.79%
0.18
4,967.57%
-0.00
102.42%
-0.03
554.51%
-0.06
106.07%
-0.03
54.02%
0.09
431.57%
revenue per share
14.71
-
14.90
1.31%
13.98
6.19%
9.55
31.64%
10.12
5.87%
10.59
4.70%
12.24
15.53%
13.03
6.48%
13.04
0.10%
17.30
32.65%
roe
0.04
-
-0.20
600.47%
-0.13
36.52%
-0.01
92.07%
0.37
3,745.54%
-0.01
102.68%
-0.07
621.49%
-0.17
134.03%
-0.09
48.83%
0.25
398.95%
roic
0.03
-
-0.10
489.33%
0.06
156.19%
-0.01
113.15%
0.03
455.55%
-0.03
193.46%
-0.01
42.77%
-0.06
295.92%
-0.01
76.53%
0.13
1,056.02%
sales general and administrative to revenue
0.05
-
0.06
11.21%
0.06
5.40%
0.12
87.84%
0.08
33.97%
0.07
5.39%
0.06
22.02%
0.06
0.24%
0.06
5.21%
shareholders equity per share
12.13
-
10.42
14.14%
9.11
12.54%
8.78
3.58%
12.51
42.41%
12.05
3.66%
11.16
7.40%
9.61
13.86%
9.38
2.44%
12.61
34.44%
stock based compensation to revenue
-0.04
-
tangible asset value
430M
-
367.60M
14.51%
335.40M
8.76%
331.20M
1.25%
478.80M
44.57%
463.10M
3.28%
427.60M
7.67%
369.20M
13.66%
354.70M
3.93%
492.90M
38.96%
tangible book value per share
10.87
-
9.29
14.51%
8.48
8.76%
8.37
1.25%
12.10
44.57%
11.70
3.28%
10.81
7.67%
9.33
13.66%
8.96
3.93%
12.46
38.96%
working capital
550.40M
-
461M
16.24%
321.20M
30.33%
198.50M
38.20%
369.50M
86.15%
407.80M
10.37%
450.70M
10.52%
415.80M
7.74%
489.20M
17.65%
371.20M
24.12%

All numbers in EUR (except ratios and percentages)